In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity (2011)
- Authors:
- USP affiliated authors: CARVALHO, IVONE - FCFRP ; SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.4155/fmc.11.67
- Assunto: DOENÇA DE ALZHEIMER (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 3, n. 8, p. 947-960, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Vinícius Barreto da et al. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity. Future Medicinal Chemistry, v. 3, n. 8, p. 947-960, 2011Tradução . . Disponível em: https://doi.org/10.4155/fmc.11.67. Acesso em: 16 jan. 2026. -
APA
Silva, V. B. da, Andrade, P. de, Kawano, D. F., Morais, P. A. B., Almeida, J. R. de, Carvalho, I., et al. (2011). In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity. Future Medicinal Chemistry, 3( 8), 947-960. doi:10.4155/fmc.11.67 -
NLM
Silva VB da, Andrade P de, Kawano DF, Morais PAB, Almeida JR de, Carvalho I, Taft CA, Silva CHT de P da. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity [Internet]. Future Medicinal Chemistry. 2011 ; 3( 8): 947-960.[citado 2026 jan. 16 ] Available from: https://doi.org/10.4155/fmc.11.67 -
Vancouver
Silva VB da, Andrade P de, Kawano DF, Morais PAB, Almeida JR de, Carvalho I, Taft CA, Silva CHT de P da. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity [Internet]. Future Medicinal Chemistry. 2011 ; 3( 8): 947-960.[citado 2026 jan. 16 ] Available from: https://doi.org/10.4155/fmc.11.67 - Using computer-aided drug design and medicinal chemistry strategies in the fight against diabetes
- Combinatorial chemistry underpinning drug discovery and development
- Cyclooligomerisation of azido-alkyne-functionalised sugars: synthesis of 1,6-linked cyclic pseudo-galactooligosaccharides and assessment of their sialylation by Trypanosoma cruzi trans-sialidase
- Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK2 inhibitors in cancer therapy
- Novel aryl 'beta'-aminocarbonyl derivates as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures
- Disaccharide glycosides and glycopeptides as potential acceptor substrates for Trypanosoma cruzi trans-sialidase
- Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- General aspects of lead finding and optimization in drug discovery
Informações sobre o DOI: 10.4155/fmc.11.67 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
